Cargando…

Group-based trajectory modeling to assess adherence to biologics among patients with psoriasis

BACKGROUND: Proportion of days covered (PDC), a commonly used adherence metric, does not provide information about the longitudinal course of adherence to treatment over time. Group-based trajectory model (GBTM) is an alternative method that overcomes this limitation. METHODS: The statistical princi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Yunfeng, Zhou, Huanxue, Cai, Beilei, Kahler, Kristijan H, Tian, Haijun, Gabriel, Susan, Arcona, Steve
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2014
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3986333/ https://www.ncbi.nlm.nih.gov/pubmed/24748809 http://dx.doi.org/10.2147/CEOR.S59339

Ejemplares similares

Difference-in-Differences Method in Comparative Effectiveness Research: Utility with Unbalanced Groups
por: Zhou, Huanxue, et al.
Publicado: (2016)

Inhaled corticosteroid use in patients with chronic obstructive pulmonary disease and the risk of pneumonia: a retrospective claims data analysis
por: Yawn, Barbara P, et al.
Publicado: (2013)

Costs and health care resource utilization among chronic obstructive pulmonary disease patients with newly acquired pneumonia
por: Lin, Junji, et al.
Publicado: (2014)

Economic Burden Associated with Extrapyramidal Symptoms in a Medicaid Population with Schizophrenia
por: Abouzaid, Safiya, et al.
Publicado: (2012)

Resource utilization, costs and treatment patterns of switching and discontinuing treatment of MS patients with high relapse activity
por: Raimundo, Karina, et al.
Publicado: (2013)

Assessing the importance of predictors in unplanned hospital readmissions for chronic obstructive pulmonary disease
por: Yu, Tzy-Chyi, et al.
Publicado: (2015)

Economic impact of biologic utilization patterns in patients with psoriatic arthritis
por: Schwartzman, Sergio, et al.
Publicado: (2017)

Group‐Based Trajectory Models: Assessing Adherence to Antihypertensive Medication in Older Adults in a Community Pharmacy Setting
por: Dillon, Paul, et al.
Publicado: (2017)

COVID-19 and adherence to biologic therapies for psoriasis: An analysis of nationwide pharmacy claims data
por: He, Meiqi, et al.
Publicado: (2022)

Adherence to guidelines in the use of biological agents to treat psoriasis in Brazil
por: Silveira, Miriam Sanches do Nascimento, et al.
Publicado: (2014)

Adherence and Persistence to Biological Drugs for Psoriasis: Systematic Review with Meta-Analysis
por: Piragine, Eugenia, et al.
Publicado: (2022)

Persistence and Adherence to Biologics in Patients with Psoriasis in Taiwan: A New Biologics User Cohort Study
por: Huang, Yu-Huei, et al.
Publicado: (2022)

Refractory Pediatric Psoriasis and Atopic Dermatitis: The Importance of Therapeutical Adherence and Biological Management
por: Kelly, Katherine A., et al.
Publicado: (2021)

Using group based trajectory modeling for assessing medication adherence to nintedanib among idiopathic pulmonary fibrosis patients
por: Nili, Mona, et al.
Publicado: (2023)

An assessment of Parkinson’s disease medication treatment patterns in the Medicaid population
por: Johnsrud, Michael, et al.
Publicado: (2021)

Psoriasis flares after COVID-19 vaccination: adherence to biologic therapy reduces psoriasis exacerbations: a case-control study
por: Burlando, Martina, et al.
Publicado: (2023)

Secondary Use of Data: Non-Interventional Study Best Practices in Planning and Protocol Development
por: Fang, Juanzhi, et al.
Publicado: (2017)

Biologics for psoriasis patients under 18 years of age: Real-world evidence from the Chinese psoriasis real world evidence research group
por: Zheng, Yu-Xin, et al.
Publicado: (2022)

Economic Burden of COPD in the Presence of Comorbidities
por: Mannino, David M., et al.
Publicado: (2015)

Cluster analysis and its application to healthcare claims data: a study of end-stage renal disease patients who initiated hemodialysis
por: Liao, Minlei, et al.
Publicado: (2016)

BIOLOGICAL THERAPY OF PSORIASIS
por: Sivamani, Raja K, et al.
Publicado: (2010)

Biologics in the management of psoriasis
por: Bahner, Jennifer D, et al.
Publicado: (2009)

Biologics and Biosimilars in Psoriasis
por: Ahmed, Sk Shahriar, et al.
Publicado: (2023)

Available Alternative Biologics and Disease Groups Influence Biologic Drug Survival in Patients with Psoriasis and Psoriatic Arthritis
por: Oh, Sohee, et al.
Publicado: (2022)

Assessment and monitoring of biologic drug adverse events in patients with psoriasis
por: Hanley, Tessa, et al.
Publicado: (2016)

Mapping the use of Group-Based Trajectory Modelling in medication adherence research: A scoping review protocol
por: Walsh, Caroline A., et al.
Publicado: (2020)

Medication Adherence Patterns after Hospitalization for Coronary Heart Disease. A Population-Based Study Using Electronic Records and Group-Based Trajectory Models
por: Librero, Julián, et al.
Publicado: (2016)

Trajectories of Adherence to Biologic Disease-Modifying Anti-Rheumatic Drugs in Tuscan Administrative Databases: The Pathfinder Study
por: Convertino, Irma, et al.
Publicado: (2021)

Longitudinal Trajectory Modeling to Assess Adherence to Sacubitril/Valsartan among Patients with Heart Failure
por: Mucherino, Sara, et al.
Publicado: (2023)

Assessing Concurrent Adherence to Combined Essential Medication and Clinical Outcomes in Patients With Acute Coronary Syndrome. A Population-Based, Real-World Study Using Group-Based Trajectory Models
por: Rodríguez-Bernal, Clara L., et al.
Publicado: (2022)

Psoriasis in Pediatric Age Group
por: Dhar, Sandipan, et al.
Publicado: (2022)

Assessing brain and biological aging trajectories associated with Alzheimer’s disease
por: Liang, Winnie S., et al.
Publicado: (2022)

Psoriasis in childhood: effective strategies to improve treatment adherence
por: Shah, Kara N, et al.
Publicado: (2015)

Erratum to: Benefits of applying a proxy eligibility period when using electronic health records for outcomes research: a simulation study
por: Yu, Tzy-Chyi, et al.
Publicado: (2015)

Benefits of applying a proxy eligibility period when using electronic health records for outcomes research: a simulation study
por: Yu, Tzy-Chyi, et al.
Publicado: (2015)

Impact of the COVID-19 pandemic on healthcare resource utilization across selected disease areas in the USA
por: Engelbrecht, Kayla, et al.
Publicado: (2022)

Remote Patient Monitoring via Non-Invasive Digital Technologies: A Systematic Review
por: Vegesna, Ashok, et al.
Publicado: (2017)

Dopamine agonist monotherapy utilization in patients with Parkinson’s disease
por: Frazer, Monica, et al.
Publicado: (2022)

Real‐world antiseizure medication treatment outcomes in drug‐resistant focal epilepsy patients
por: Hatoum, Hind T., et al.
Publicado: (2023)

The cost of biologics for psoriasis is increasing
por: Cheng, Judy, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_d0mo16ba8k9ctuoo2joe8o6dm9